PENG and LFCN Block Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty

Post Operative Pain Clinical Trial

Official title:

Efficacy and Safety of Ultrasound Guided Combined Pericapsular Nerve Group Block and Lateral Femoral Cutaneous Nerve Versus Lumbar Plexus Block for Postoperative Analgesia After Total Hip Arthroplasty: Randomized Clinical Study.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05652075
• Other study ID #: 473:10/2022
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2023
• Est. completion date: February 1, 2024

Study information

• Verified date: October 2023
• Source: Minia University
• Contact: hassan m. hetta, lecturer
• Phone: 1010901114
• Email: hassan.hetta[@]mu.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Regional anesthesia for postoperative analgesia in THA includes epidural anesthesia and peripheral nerve blocks. However epidural anesthesia has a great role in THA, it has become restricted as perioperative antithrombotic drugs are generally used for orthopedic patients. the study aim to evaluate and compare efficacy and safety of pericapsular nerve group block (PENG) block and lateral femoral cutaneous nerve versus Lumbar plexus block on postoperative analgesia in hip surgery.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 66
• Est. completion date: February 1, 2024
• Est. primary completion date: January 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 30 Years to 70 Years

Eligibility

Inclusion Criteria:

(ASA) physical status I to III scheduled for hip surgery aged (30-70) years

Exclusion Criteria:

• Drug allergy,
• Morbid obesity (BMI >40 kg/m2),
• Coagulopathy,
• Psychiatric disorder,
• Opioid dependence,
• Patient refusal to give informed consent.

Related Conditions & MeSH terms

• Pain, Postoperative
• Post Operative Pain
• Regional Block

Intervention

Procedure:
• pericapsular nerve group and lateral femoral cutaneous nerve block
Will undergo pericapsular nerve group block (PENG) combined with lateral femoral cutaneous nerve under ultrasound guided block with 20 mL of 0.25% bupivacaine.
• lumbar plexus block
Will undergo Lumbar plexus block (LPB) under ultrasound guided block with 20 mL of 0.25 % bupivacaine.

Locations

Country	Name	City	State
Egypt	Minia University	Minya	Minia

Sponsors (1)

Lead Sponsor	Collaborator
Minia University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual analogue scale pain scores	pain score from 0-10 which 0 mean no pain and 10 the worst pain	24 hour
Secondary	first analgesic request	time to demand nalbuphine	24 hour
Secondary	total analgesic consumption	total nalbuphine in mg consumed in the first day	24 hour
Secondary	First time to ambulate	first time to move	24 hours